Thoracic Cancer | 2019
Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients
Abstract
Achaete‐scute homolog 1 (ASCL1) is a basic helix‐loop‐helix transcription factor and is essential in the differentiation of neuroendocrine cells and neural tissues. ASCL1 is frequently overexpressed in small cell lung cancer (SCLC) and plays a crucial role in the pathogenesis of SCLC.